Evidence map›Paper›PMID 34829235›Full record

ArticleJournal of fungi (Basel, Switzerland)2021

COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020-March 2021.

Geetha Sivasubramanian, Hebah Ghanem, Michele Maison-Fomotar, Ratnali Jain, Robert Libke

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Observational
  3. Review
  4. Post-COVID-19 fatal Aspergillus endocarditis: A case report.Journal of clinical laboratory analysis · 2023
    Article
  5. Current Issues in Fungal Infections and COVID-19.Journal of fungi (Basel, Switzerland) · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Geetha SivasubramanianDivision of Infectious Diseases, Department of Internal Medicine, University of California, San Francisco, CA 93701, USA.ORCID 0000-0002-8443-7095
Hebah GhanemDivision of Infectious Diseases, Department of Internal Medicine, University of California, San Francisco, CA 93701, USA.
Michele Maison-FomotarDivision of Infectious Diseases, Department of Internal Medicine, University of California, San Francisco, CA 93701, USA.
Ratnali JainUCSF Fresno Research Institute, University of California, San Francisco, CA 93701, USA.
Robert LibkeDivision of Infectious Diseases, Department of Internal Medicine, University of California, San Francisco, CA 93701, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reports of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) have been widely published across the world since the onset of the pandemic with varying incidence rates. We retrospectively studied all patients with severe COVID-19 infection who were admitted to our tertiary care center's intensive care units between January 2020 and March 2021, who also had respiratory cultures positive for

Indexed as

CAPACovid-19invasive pulmonary aspergillosis

Identifiers

PMID34829235
PMCPMC8618928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.